Login
ProSomnus, Inc. logo

ProSomnus, Inc.

prosomnus.com

No Longer Reporting

The company has not filed an annual or quarterly report since its Q2 FY2024 10-Q, filed Jul 31, 2024. Its latest SEC filing is a SC 13G/A from Nov 13, 2024.

The sections below describe the company as of the FY2023 annual report.

What Did They Do?

Sells personalized oral devices for treating obstructive sleep apnea to sleep physicians and therapy providers.

How Did They Make Money?

Customers order customized intraoral devices by submitting a prescription and oral scan; the company earns revenue when it delivers the completed device.

FY2023 revenue

Who Were Their Customers?

Sells directly through its sales force to sleep-medicine physicians and therapy providers, including dentists and other clinicians.

Did Revenues Turn Into Profits?

No. It lost $24.1M in FY2023.

Operating income, FY2023
−69% of revenue
▲ +67% (Loss) vs FY2022 (−$11.5M, −59%)
Net income, FY2023
−87% of revenue
▲ +237% (Loss) vs FY2022 (−$7.1M, −37%)
Free cash flow, FY2023
−64% of revenue
▲ +52% (Loss) vs FY2022 (−$11.6M, −60%)

How Were They Changing?

Since the FY2023 annual report
Latest quarter: Q2 FY2024, the three months to Jun 30, 2024
Revenue
▲ +31%
vs $6.9M in Q2 FY2023
Net income
▼ Now a loss
vs $905K in Q2 FY2023
  • Jul 31, 2024 Bankruptcy court confirmed the reorganization plan; existing shares will be canceled The plan says common stock and warrants will be canceled with no distribution, and the company will cease to be publicly traded.
  • May 8, 2024 Company filed for Chapter 11 and agreed to a restructuring The proposed plan included debtor-in-possession loans and a possible new-money equity raise.
  • Apr 30, 2024 Nasdaq initiated delisting of the company's securities Trading was suspended on Nasdaq, and the company said its securities moved to over-the-counter trading.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support